开发一条高产的子系,用于增强动物药剂的开发
Jun Song1, Dongshan Yang1, Lingjie Kong2
1Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, Ann Arbor, MI, 48109, USA.
Biological research
|December 10, 2025
概括
研究人员使用一种新的基因编辑技术在转基因子中增强了重组蛋白质的产生. 这种方法显著提高了产量,为药物开发提供了更有效的动物药物制剂方法.
科学领域:
- 生物技术是生物技术.
- 遗传学 是一个遗传学.
- 动物制药是动物的制药.
背景情况:
- 动物制药利用转基因动物用于重组蛋白药物生产.
- 目前在子中使用常规转基因的方法产生较低的蛋白质水平 (1-2 g/L).
- 挑战包括不可预测的成功率和不受控制的转基因整合.
研究的目的:
- 为了提高转基因子的重组蛋白质产量.
- 研究使用原生牛奶蛋白基因促进剂用于转基因表达的方法.
- 开发一个更有效的动物药剂策略.
主要方法:
- 使用CRISPR/Cas9和RS-1技术生成了敲进子.
- 利用CSN2基因促进器来驱动tdTomato的表达.
- 产生异合体和同合体的 knock-in 后代.
主要成果:
- 实现了显著更高的重组蛋白产量.
- 同卵同卵的子产生了15-20g/L的tdTomato.
- 证明了击中等位基因的成功传播.
结论:
- 使用CSN2促进剂可增强子的重组蛋白质生产.
- 通过CRISPR/Cas9与RS-1进行的敲击是有效的,用于产生高产的养动物.
- 这一战略为转基因子的制药生产提供了有前途的进展.
相关概念视频
Cloning of Dolly the Sheep
7.0K
The first successfully cloned mammal was Dolly, a sheep, born on 5th July 1996 at Roslin Institute, Scotland. The cloned sheep was named after the American singer Dolly Parton. Dolly lived for seven years and died of respiratory complications, which is speculated to be due to the actual age of her DNA. Because the DNA in cloned cells belongs to an older individual, the cloned individual’s life expectancy may be affected. Indeed, analysis of Dolly’s DNA revealed shorter...
7.0K
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K


